Loading…
Attending this event?
Back To Schedule
Thursday, June 16 • 2:00pm - 5:00pm
42P: Become a DCT Master: Understanding the Lifecycle of Decentralized Clinical Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Tutorial

Preregistration required and is an additional fee. Already registered? Log in to DIA's My Account/My Events.

With a growing industry trend to incorporate decentralizing solutions in trial design, what does it really mean to run a Decentralized Clinical Trial and how is it any different than running traditional clinical trials? What new technologies are needed, and do these technological advancements require new processes and organizational structure changes? In this short course, you will learn some of the foundational elements of designing decentralized clinical trials/ hybrid trials, and how these advancements in trial design impact all of the stakeholders involved including the patient, sponsor, and site. At the end of the course, you will become Medidata certified in Mastering DCTs.

Registration info: Rate: $350
Need approval in order to attend? Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
Enhance your experience and register for two or more short courses at the same time and receive $50 in savings. 
Purchase must happen at same time. Discount will be reflected on the last page of the cart.Upon completion of registration, participants will gain access to the following:
  • Live Event Access
  • Presentation Slides



Download Registration Form
Registration Questions? Send Email
1.888.257.6457

Return to DIA 2021 

Who should attend?

Head of ClinOps, Head of Innovation, Head of Patient Engagement and Recruitment

Learning Objectives

At the conclusion of this short course, participants should be able to:
  • Distinguish what defines decentralized clinical trials/hybrid trials and the foundational elements
  • Describe how decentralized clinical trials/hybrid trials operate at the patient and site levels and how to optimize the experience for patients, sponsors, and sites
  • Identify regulatory and privacy considerations when considering decentralizing solutions



Speakers
avatar for Brian Barnes

Brian Barnes

Senior Director, Product Development - RBQM, Medidata, A Dassault Systèmes company, United States
Brian Barnes is a Senior Director, Product Development – RBQM for Medidata Solutions. Brian has 16 years in clinical development and has specifically supported RBQM for ten years specializing in operational solutions for small to large pharma, biopharma, and biotech companies. Brian... Read More →
AH

Aryana Hosseinkhani

Senior Director Product Marketing, Patient Cloud, Medidata, a Dassault Systèmes company, United States
Aryana Hosseinkhani is the Senior Director of Product Marketing in Patient Cloud at Medidata, a Dassault Systemes Company. She completed her education at the University of California, Davis in Genetics and shortly after began working as a bench scientist in stem cell research. Aryana... Read More →
HR

Holly Robertson

Senior Director, Advisory & Enablement Services, Medidata, a Dassault Systèmes company, United States
Holly Robertson is the Sr. Director of Advisory & Enablement Services within the Patient Cloud team at Medidata Solutions, with over 20 years of experience in pre-clinical and clinical research. Dr. Robertson obtained her PhD in Pharmacology from the University of Colorado Health... Read More →
avatar for Michael Tucker

Michael Tucker

Medidata, a Dassault Systèmes Company, United States
Michael is a member of Medidata’s Mobile Health team and is a subject matter expert in electronic informed consent and virtual trials. Over the last six years, Michael has worked collaboratively with sponsors, CROs, regulators, ethics committees and researchers around the world... Read More →


Thursday June 16, 2022 2:00pm - 5:00pm CDT
Virtual McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616